HIVE Blockchain Technologies (CVE:HIV) Upgraded by Cantor Fitzgerald to Strong-Buy Rating

HIVE Blockchain Technologies (CVE:HIV) was upgraded by investment analysts at Cantor Fitzgerald to a “strong-buy” rating in a research note issued to investors on Tuesday, Zacks.com reports.

A number of other analysts have also recently weighed in on HIV. HC Wainwright raised shares of HIVE Blockchain Technologies from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 15th. Northland Capmk upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Thursday, September 19th.

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies (CVE:HIV) last announced its quarterly earnings data on Monday, August 12th. The company reported C($0.11) earnings per share for the quarter, missing the consensus estimate of C($0.10) by C($0.01). The firm had revenue of C$44.11 million during the quarter, compared to the consensus estimate of C$43.64 million.

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.